The paper includes four pieces of “high-value care advice:”
- Clinicians should not perform testing or initiate antibiotic therapy in patients with bronchitis unless pneumonia is suspected.
- Clinicians should test patients with symptoms suggestive of group A streptococcal pharyngitis (for example, persistent fevers, anterior cervical adenitis and tonsillopharyngeal exudates or other appropriate combination of symptoms) by rapid antigen detection test and/or culture for group A streptococcus. Clinicians should treat patients with antibiotics only if they have confirmed streptococcal pharyngitis.
- Clinicians should reserve antibiotic treatment for acute rhinosinusitis for patients with persistent symptoms for more than 10 days, onset of severe symptoms or signs of high fever (>102.2 °F) and purulent nasal discharge or facial pain lasting for at least three consecutive days, or onset of worsening symptoms following a typical viral illness that lasted five days that was initially improving (double sickening).
- Clinicians should not prescribe antibiotics for patients with the common cold.
“Inappropriate use of antibiotics for acute respiratory tract infections is an important factor contributing to the spread of antibiotic-resistant infections, which is a public health threat,” ACP president Wayne Riley, MD, said in a news release accompanying the guidelines. “Reducing overuse of antibiotics for ARTIs in adults is a clinical priority and a High Value Care way to improve quality of care, lower health care costs, and slow and/or prevent the continued rise in antibiotic resistance.”
More articles on infection control:
20 clinical research findings to know this week
Olympus asks hospitals to return Q180V duodenoscopes for redesign
NIH commits $5M to fund research projects on antibiotic alternatives
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
